InsiderDirector

BVF PARTNERS L P/IL Insider Trading Activity

Every SEC Form 4 transaction reported by BVF PARTNERS L P/IL, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · SEC Form 4 & insider trading data analysts
Last updated:

Quick Answer

Is BVF PARTNERS L P/IL buying or selling?

BVF PARTNERS L P/IL reported 95 open-market buys ($413.6M) and 25 sells ($995.4M) across 120 Form 4 filings at 23 companies — a net selling position of $581.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 26, 2026)

Total Form 4 filings
120
SEC EDGAR
Companies
23
Buys (95)
$413.6M
Sells (25)
$995.4M

Insider sentiment

Net selling

Net insider flow of $581.8M in net selling, filed between Feb 13, 2018 – Jun 26, 2026.

Companies BVF PARTNERS L P/IL files for

#CompanyForm 4 filings
1XOMAXOMA Corp25
2MRUSMerus N.V.14
3FPRXFIVE PRIME THERAPEUTICS, INC.12
4KYMRKymera Therapeutics, Inc.11
5INFIINFINITY PHARMACEUTICALS, INC.8
6RAINRain Therapeutics Inc.7
7RPTXRepare Therapeutics Inc.6
8CALACalithera Biosciences, Inc.4
9OLMAOlema Pharmaceuticals, Inc.4
10ARQLARQULE INC3

Recent BVF PARTNERS L P/IL transactions

DateTickerRoleTypeSharesValue
Jun 26, 2026KYMRDirectorSale1.6M$173.7M
Apr 2, 2026MLTXDirector, 10% OwnerSale3.8M$63.0M
Aug 7, 2025EPIX10% OwnerSale156$292.95
Jul 1, 2025KYMRDirectorPurchase317.2K$14.0M
May 20, 2025XOMA10% OwnerSale392.7K$10.6M
Jan 28, 2025XOMA10% OwnerSale650.7K$17.0M
Oct 31, 2024THRDOtherSale1.0M$14.3M
Oct 8, 2024MLTXDirector, 10% OwnerSale2.0M$100.0M
May 13, 2024ELDN10% OwnerPurchase1.9M$0
Dec 20, 2023PNTOtherSale17.2M$213.7M
Nov 17, 2023RPTX10% OwnerPurchase1.2M$6.2M
Nov 6, 2023KYMRDirectorPurchase414.1K$5.3M
Nov 3, 2023RPTX10% OwnerPurchase783.7K$2.8M
Sep 14, 2023OLMADirector, 10% OwnerPurchase1.5M$14.8M
May 10, 2023ELDN10% OwnerPurchase2.0M$0
Jan 13, 2023KYMRDirectorPurchase41.0K$1.3M
Jan 9, 2023XOMADirector, 10% OwnerPurchase22.2K$420.7K
Dec 22, 2022THRD10% OwnerPurchase214.1K$879.5K
Nov 10, 2022RAINDirector, 10% OwnerPurchase1.7M$10.0M
Sep 27, 2022XOMADirector, 10% OwnerPurchase24.6K$409.3K
Sep 16, 2022XOMADirector, 10% OwnerPurchase56.3K$990.7K
Aug 23, 2022KYMRDirectorPurchase545.5K$14.2M
Aug 11, 2022CTICDirector, 10% OwnerSale8.5M$52.0M
Jun 15, 2022RPTX10% OwnerPurchase149.2K$1.9M
Jun 14, 2022OLMADirector, 10% OwnerPurchase200.0K$806.9K

Showing the 25 most recent filings of 120. Screen every filing.

BVF PARTNERS L P/IL insider trading FAQ

Is BVF PARTNERS L P/IL buying or selling?

Across 120 SEC Form 4 filings, BVF PARTNERS L P/IL reported 95 open-market purchases totaling $413.6M and 25 sales totaling $995.4M — a net selling position of $581.8M.

Which companies does BVF PARTNERS L P/IL file Form 4s for?

BVF PARTNERS L P/IL has reported insider transactions at 23 companies, most often XOMA Corp (XOMA), Merus N.V. (MRUS), FIVE PRIME THERAPEUTICS, INC. (FPRX), Kymera Therapeutics, Inc. (KYMR), INFINITY PHARMACEUTICALS, INC. (INFI).

How far back does BVF PARTNERS L P/IL's filing history go?

Trabud holds BVF PARTNERS L P/IL's SEC Form 4 filings from Feb 13, 2018 – Jun 26, 2026, sourced directly from SEC EDGAR.

Where does Trabud get BVF PARTNERS L P/IL's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track BVF PARTNERS L P/IL and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener